Muutke küpsiste eelistusi

E-raamat: Statistical Evaluation of Medical Tests for Classification and Prediction

(Professor of Biostatistics, University of Washington; Fred Hutchinson Cancer Research Center, Washington, USA)
  • Formaat - PDF+DRM
  • Hind: 85,20 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This is a paperbound reprint of a 2003 book. Describing statistical concepts and techniques for evaluating the accuracy of medical tests, this text covers estimation and comparison of measures of accuracy, regression frameworks, sample size calculations, and other issues pertinent to study design. Problems relating to missing and imperfect reference data are discussed, and procedures for combining the results of multiple tests to improve classification are presented. The book's audience includes quantitative researchers and practicing and academic statisticians. Pepe teaches biostatistics at the University of Washington. Annotation ©2004 Book News, Inc., Portland, OR (booknews.com)

This book describes statistical concepts and techniques for evaluating medical diagnostic tests and biomarkers for detecting disease. More generally, the techniques pertain to the statistical classification problem for predicting a dichotomous outcome. Measures for quantifying test accuracy are described including sensitivity, specificity, predictive values, diagnostic likelihood ratios and the Receiver Operating Characteristic Curve that is commonly used for continuous and ordinal valued tests. Statistical procedures are presented for estimating and comparing them. Regression frameworks for assessing factors that influence test accuracy and for comparing tests while adjusting for such factors are presented. This book presents many worked examples of real data and should be of interest to practicing statisticians or quantitative researchers involved in the development of tests for classification or prediction in medicine.

Arvustused

Statistical results are given a methodical treatment. In each chapter statistical results are motivated, stated and usually proven, and then illustrated on a variety of datasets based on actual trials. Many of the results were developed by Pepe and her colleagues, who have advanced the field in seminal ways. Chapters end with a concluding remarks section, a set of exercises, and proofs of more involved theoretical results, when needed. Concluding remarks sections nicely summarize results and discuss open research questions. References to key papers are given throughout. This structure allows the book to serve as both a classroom text and an excellent reference to the current literature. * Journal of Biopharmaceutical Studies * I very much recommend this book to a range of audiences, from those wanting an introduction to diagnostic test concepts and methods to active researchers in the area. This book is likely to stimulate considerable progress in development of new statistical methods for diagnostic tests, an area that relative to therapeutics has received little attention from biostatisticians. * Journal of Biopharmaceutical Studies *

Notation xv
Introduction
1(13)
The medical test
1(2)
Tests, classification and the broader context
1(1)
Disease screening versus diagnosis
2(1)
Criteria for a useful medical test
2(1)
Elements of study design
3(5)
Scale for the test result
4(1)
Selection of study subjects
4(1)
Comparing tests
5(1)
Test integrity
5(1)
Sources of bias
6(2)
Examples and datasets
8(3)
Overview
8(1)
The CASS dataset
8(2)
Pancreatic cancer serum biomarkers study
10(1)
Hepatitis metastasis ultrasound study
10(1)
CARET PSA biomarker study
10(1)
Ovarian cancer gene expression study
11(1)
Neonatal audiology data
11(1)
St Louis prostate cancer screening study
11(1)
Topics and organization
11(1)
Exercises
12(2)
Measures of accuracy for binary tests
14(21)
Measures of accuracy
14(7)
Notation
14(1)
Disease-specific classification probabilities
14(2)
Predictive values
16(1)
Diagnostic likelihood ratios
17(4)
Estimating accuracy with data
21(6)
Data from a cohort study
21(1)
Proportions: (FPF, TPF) and (PPV, NPV)
22(2)
Ratios of proportions: DLRs
24(1)
Estimation from a case-control study
25(1)
Merits of case-control versus cohort studies
26(1)
Quantifying the relative accuracy of tests
27(6)
Comparing classification probabilities
28(1)
Comparing predictive values
29(1)
Comparing diagnostic likelihood ratios
30(1)
Which test is better?
31(2)
Concluding remarks
33(1)
Exercises
34(1)
Comparing binary tests and regression analysis
35(31)
Study designs for comparing tests
35(2)
Unpaired designs
35(1)
Paired designs
36(1)
Comparing accuracy with unpaired data
37(4)
Empirical estimators of comparative measures
37(1)
Large sample inference
38(3)
Comparing accuracy with paired data
41(7)
Sources of correlation
41(1)
Estimation of comparative measures
41(1)
Wide or long data representations
42(1)
Large sample inference
43(1)
Efficiency of paired versus unpaired designs
44(1)
Small sample properties
45(1)
The CASS study
45(3)
The regression modeling framework
48(3)
Factors potentially affecting test performance
48(2)
Questions addressed by regression modeling
50(1)
Notation and general set-up
50(1)
Regression for true and false positive fractions
51(7)
Binary marginal GLM models
51(1)
Fitting marginal models to data
51(2)
Illustration: factors affecting test accuracy
53(2)
Comparing tests with regression analysis
55(3)
Regression modeling of predictive values
58(3)
Model formulation and fitting
58(1)
Comparing tests
59(1)
The incremental value of a test for prediction
59(2)
Regression models for DLRs
61(2)
The model form
61(1)
Fitting the DLR model
61(1)
Comparing DLRs of two tests
61(1)
Relationships with other regression models
62(1)
Concluding remarks
63(1)
Exercises
64(2)
The receiver operating characteristic curve
66(30)
The context
66(1)
Examples of non-binary tests
66(1)
Dichotomizing the test result
66(1)
The ROC curve for continuous tests
67(9)
Definition of the ROC
67(1)
Mathematical properties of the ROC curve
68(3)
Attributes of and uses for the ROC curve
71(4)
Restrictions and alternatives to the ROC curve
75(1)
Summary indices
76(5)
The area under the ROC curve (AUC)
77(2)
The ROC(t0) and partial AUC
79(1)
Other summary indices
80(1)
Measures of distance between distributions
81(1)
The binormal ROC curve
81(4)
Functional form
82(1)
The binormal AUC
83(1)
The binormal assumption
84(1)
The ROC for ordinal tests
85(7)
Tests with ordered discrete results
85(1)
The latent decision variable model
86(1)
Identification of the latent variable ROC
86(2)
Changes in accuracy versus thresholds
88(1)
The discrete ROC curve
89(3)
Summary measures for the discrete ROC curve
92(1)
Concluding remarks
92(2)
Exercises
94(2)
Estimating the ROC curve
96(34)
Introduction
96(1)
Approaches
96(1)
Notation and assumptions
96(1)
Empirical estimation
97(14)
The empirical estimator
97(2)
Sampling variability at a threshold
99(1)
Sampling variability of ROCe(t)
99(4)
The empirical AUC and other indices
103(1)
Variability in the empirical AUC
104(3)
Comparing empirical ROC curves
107(2)
Illustration: pancreatic cancer biomarkers
109(1)
Discrete ordinal data ROC curves
110(1)
Modeling the test result distributions
111(3)
Fully parametric modeling
111(1)
Semiparametric location-scale models
112(2)
Arguments against modeling test results
114(1)
Parametric distribution-free methods: ordinal tests
114(5)
The binormal latent variable framework
115(2)
Fitting the discrete binormal ROC function
117(1)
Generalizations and comparisons
118(1)
Parametric distribution-free methods: continuous tests
119(6)
LABROC
119(1)
The ROC--GLM estimator
120(4)
Inference with parametric distribution-free methods
124(1)
Concluding remarks
125(2)
Exercises
127(1)
Proofs of theoretical results
128(2)
Covariate effects on continuous and ordinal tests
130(38)
How and why?
130(6)
Notation
130(1)
Aspects to model
131(1)
Omitting covariates/pooling data
132(4)
Reference distributions
136(8)
Non-diseased as the reference population
136(1)
The homogenous population
137(2)
Nonparametric regression quantiles
139(1)
Parametric estimation of SD,Z
140(1)
Semiparametric models
141(1)
Application
141(2)
Ordinal test results
143(1)
Modeling covariate effects on test results
144(7)
The basic idea
144(1)
Induced ROC curves for continuous tests
144(4)
Semiparametric location-scale families
148(2)
Induced ROC curves for ordinal tests
150(1)
Random effect models for test results
150(1)
Modeling covariate effects on ROC curves
151(13)
The ROC--GLM regression model
152(2)
Fitting the model to data
154(3)
Comparing ROC curves
157(2)
Three examples
159(5)
Approaches to ROC regression
164(2)
Modeling ROC summary indices
164(1)
A qualitative comparison
164(2)
Concluding remarks
166(1)
Exercises
167(1)
Incomplete data and imperfect reference tests
168(46)
Verification biased sampling
168(12)
Context and definition
168(2)
The missing at random assumption
170(1)
Correcting for bias with Bayes' theorem
170(1)
Inverse probability weighting/imputation
171(1)
Sampling variability of corrected estimates
172(3)
Adjustments for other biasing factors
175(2)
A broader context
177(2)
Non-binary tests
179(1)
Verification restricted to screen positives
180(14)
Extreme verification bias
180(1)
Identifiable parameters for a single test
181(2)
Comparing tests
183(2)
Evaluating covariate effects on (DP, FP)
185(2)
Evaluating covariate effects on (TPF, FPF) and on prevalence
187(2)
Evaluating covariate effects on (rTPF, rFPF)
189(4)
Alternative strategies
193(1)
Imperfect reference tests
194(13)
Examples
194(1)
Effects on accuracy parameters
194(3)
Classic latent class analysis
197(3)
Relaxing the conditional independence assumption
200(3)
A critique of latent class analysis
203(2)
Discrepant resolution
205(1)
Composite reference standards
206(1)
Concluding remarks
207(2)
Exercises
209(1)
Proofs of theoretical results
210(4)
Study design and Hypothesis testing
214(39)
The phases of medical test development
214(4)
Research as a process
214(1)
Five phases for the development of a medical test
215(3)
Sample sizes for phase 2 studies
218(11)
Retrospective validation of a binary test
218(2)
Retrospective validation of a continuous test
220(4)
Sample size based on the AUC
224(4)
Ordinal tests
228(1)
Sample sizes for phase 3 studies
229(10)
Comparing two binary tests---paired data
229(4)
Comparing two binary tests---unpaired data
233(1)
Evaluating population effects on test performance
233(1)
Comparisons with continuous test results
234(3)
Estimating the threshold for screen positivity
237(1)
Remarks on phase 3 analyses
238(1)
Sample sizes for phase 4 studies
239(6)
Designs for inference about (FPF, TPF)
239(2)
Designs for predictive values
241(2)
Designs for (FP, DP)
243(1)
Selected verification of screen negatives
244(1)
Phase 5
245(1)
Matching and stratification
246(2)
Stratification
246(1)
Matching
247(1)
Concluding remarks
248(3)
Exercises
251(2)
More topics and conclusions
253(27)
Meta-analysis
253(6)
Goals of meta-analysis
253(1)
Design of a meta-analysis study
253(2)
The summary ROC curve
255(3)
Binomial regression models
258(1)
Incorporating the time dimension
259(8)
The context
259(1)
Incident cases and long-term control
260(3)
Interval cases and controls
263(3)
Predictive values
266(1)
Longitudinal measurements
266(1)
Combining multiple test results
267(10)
Boolean combinations
267(2)
The likelihood ratio principle
269(2)
Optimality of the risk score
271(3)
Estimating the risk score
274(2)
Development and assessment of the combination score
276(1)
Concluding remarks
277(2)
Topics we only mention
277(1)
New applications and new technologies
277(2)
Exercises
279(1)
Bibliography 280(17)
Index 297